Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VictrexVTXPF 78 Days Sales Outstanding is 51.73 as of Mar. 2026, which is 26% above its 10-year median of 40.97. GuruFocus rates VTXPF with a GF Score™ of 78/100 and a GF Value™ of $13.35 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 1,581 Chemicals companies, Victrex ranks better than 61.73% on this metric.
Victrex's average Accounts Receivable for the
six
months ended in Mar. 2026 was $56.0 Mil. Victrex's Revenue for the
six
months ended in Mar. 2026 was $197.5 Mil.
Hence, Victrex's Days Sales Outstanding for the
six
months ended in Mar. 2026 was 51.73.
The historical rank and industry rank for Victrex's Days Sales Outstanding or its related term are showing as below:
VTXPF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 27.92 Med: 40.97 Max: 53.77
Current: 53.77
During the past 13 years, Victrex's highest Days Sales Outstanding was 53.77. The lowest was 27.92. And the median was 40.97.
VTXPF's Days Sales Outstanding is ranked better than 61.73% of 1581
companies
in the Chemicals industry
Industry Median: 64.5
vs VTXPF: 53.77
Victrex's Days Sales Outstanding
increased
from Mar. 2025 (50.08) to Mar. 2026 (51.73).
Victrex (OTCPK:VTXPF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Victrex Days Sales Outstanding Related Terms
Victrex Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Victrex's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VTXPF vs LIN, SHW, ECL: Days Sales Outstanding Comparison
For the Specialty Chemicals subindustry, Victrex's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Victrex Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Victrex's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Victrex's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Victrex (VTXPF) has a Days Sales Outstanding of 51.73 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Victrex and its competitors. This is 26% above median its historical median of 40.97. Over the past decade, Victrex's Days Sales Outstanding has ranged from 27.92 to 53.77. According to the industry distribution chart, Victrex ranks #605 out of 1581 companies in the Chemicals industry, placing it in the top 38.3%.
Is Victrex's Days Sales Outstanding too high?
Victrex's current Days Sales Outstanding of 51.73 is 26% above median its 10-year median of 40.97. Over the past 10 years, this metric has ranged from a low of 27.92 to a high of 53.77. The Chemicals industry median Days Sales Outstanding is 64.50. Victrex's value of 51.73 is 19.8% below this industry median. Based on the distribution chart, Victrex ranks #605 out of 1581 companies in the Chemicals industry, which is above the industry midpoint. Overall, Victrex has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Victrex's Days Sales Outstanding compare to LIN and SHW?
According to the Chemicals industry distribution chart, Victrex ranks #605 out of 1581 companies for Days Sales Outstanding. This puts Victrex in the upper half of its industry. The industry median Days Sales Outstanding is 64.50. Victrex's value of 51.73 is 19.8% below this benchmark. Historically, Victrex's own Days Sales Outstanding has ranged from 27.92 to 53.77 over the past decade. While the company's 10-year median is 40.97 vs. the industry median of 64.50, Victrex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 64.50, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Victrex's current Days Sales Outstanding of 51.73 is 19.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Victrex and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 64.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Victrex's current Days Sales Outstanding is 51.73, which is 26% above median its own 10-year median of 40.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Victrex stock overvalued right now?
Based on GuruFocus' analysis, Victrex (VTXPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.35, compared to a current price of $10.95 — trading 18% below its estimated fair value. The current Days Sales Outstanding is 51.73, which is 26% above median its 10-year median of 40.97 and 19.8% below the Chemicals industry median of 64.50. Victrex's overall GF Score™ is 78/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Victrex (VTXPF), the current Days Sales Outstanding is 51.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Victrex (VTXPF) Overvalued in 2026?
Based on GuruFocus' analysis, Victrex stock appears to be undervalued.
The current stock price of $10.95 is trading 18% below its estimated GF Value™ of $13.35.
GuruFocus considers Victrex to be Modestly Undervalued.
Key valuation signals for VTXPF:
Days Sales Outstanding: 51.73 (26% above median its 10-year median of 40.97)
GF Value™: $13.35 vs. price of $10.95 (18% below fair value)
Industry Position: 19.8% below the Chemicals median (#605 of 1581)
No single metric tells the full story. See the VTXPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Victrex PLC is a British specialty chemicals company whose business is based predominantly on manufacturing and creating solutions using polyetheretherketone, or PEEK, an ultra-high-performance lightweight plastic. The business has two segments. The Sustainable Solutions targets transportation, energy, electronics, and manufacturing, while the Medical Segment provides healthcare solutions for the implantable device markets. Geographically operates in the United Kingdom, Europe, the Middle East and Africa (EMEA), America, and Asia-Pacific. Its maximum sales are generated from the Middle East and Africa (EMEA).
78GF Score
Get the complete analysis for VTXPF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTXPF has been successfully added to your 
